編集者のレビューOncology Nursing Drug Handbook is a Medical アプリ for Android phones and tablets developed by AtmosphereApps. The latest APK version of Oncology Nursing Drug Handbook is 2.0.1.98 compatible with Nexus, Sumsung Galaxy, LG, Huawei and Kindle Fire mobile phones and android devices having system version 6.0 and higher. The last mod was released on 17-4-2020 and has google play package name com.atmoapps.onha. Please read the details about the アプリ below. Easy and fast Oncology Nursing Drug Handbook APK download of the android version 2.0.1.98 is available directly on ApkGain.com. Oncology Nursing Drug Handbook APK is the property and trademark from the developer AtmosphereApps. Please note that we only provide the original and free apk package installation without any modifications. Check our "safe download" sign to get the latest report from McAfee to see if the Oncology Nursing Drug Handbook download is completely secure. Customers who installed and used this アプリ gave over 3 user ratings with an average rating 4.0 of 5 stars relating to Oncology Nursing Drug Handbook. More than 1000 people have used this アプリ by now. Join them now and download Oncology Nursing Drug Handbook アプリ APK directly on our ApkGain.com play market!
説明
Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.
Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.
New drugs include:
apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)
ダウンロードとインストール 無料 アンドロイド apk ファイル ために Oncology Nursing Drug Handbook.
